Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microvision (MVIS) -- Ignore unavailable to you. Want to Upgrade?

To: CAP who wrote (2537)	5/13/1999 9:22:00 AM
From: Terry Jackson	Respond to of 7720

Medical innovation: biz.yahoo.com

To: CAP who wrote (2537)	5/13/1999 10:47:00 AM
From: R. Murphey	Read Replies (1) \| Respond to of 7720

CAP, More importantly, it may mean more sales potential. With easy, inexpensive, highly valid tests, these could become a screening service performed by optometrists, maybe even in your local pharmacy, and there are a lot of those types of customers. Companies could even require such tests for specific job functions related to safety, such as driving, or machine operation, although in these cases there would have to be a "willing" test subject. Additionally, insurance companies, and sight preservation funds could even help cover the costs. All kinds of possibilities here. Regards, Bob.